V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200015189 | 200006449 | null | null | Palliative (P) | 2013-09-08 | 2013-09-08 | Bortezomib + Panobinostat | N | null | 200043763 | ABC-02 TRIAL |
| 300004536 | 300003172 | 0 | 104 | Curative (C) | 2018-03-12 | 2018-03-12 | TEMOZOLOMIDE | N | N | 300024268 | ABC-02 TRIAL |
| 200015906 | 200006711 | 0.64 | null | null | 2015-10-08 | 2015-10-09 | VDT-PACE | N | N | 200022979 | ABC-02 TRIAL |
| 280005540 | 280003522 | 1.63 | 93.4 | Palliative (P) | 2017-03-01 | 2017-03-11 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 280029283 | ABC-03 TRIAL |
| 200015391 | 200006524 | 0 | 55.1 | Palliative (P) | 2015-07-15 | 2015-07-16 | PAD | 1 | Y | 200044986 | ABIRATERONE |
| 210013442 | 210017140 | 0 | 58 | Curative (C) | 2018-11-12 | 2018-11-17 | Hydroxycarbamide | N | N | 210022442 | ABIRATERONE |
| 10003473 | 10002204 | 1.71 | null | Neo-adjuvant (N) | 2017-11-30 | 2017-11-30 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10479742 | ABIRATERONE |
| 10003487 | 10002214 | 1.6 | 77.4 | Neo-adjuvant (N) | 2017-01-27 | 2017-03-09 | BCG Intravesical | 02 | N | 10480101 | ABIRATERONE |
| 10003495 | 10002220 | 1.71 | null | Adjuvant (A) | 2009-11-21 | 2017-10-11 | CTD | 2 | N | 10480234 | ABIRATERONE |
| 10003556 | 10008102 | 1.66 | 81.8 | Neo-adjuvant (N) | null | 2015-02-26 | EC | N | N | 10482023 | ABIRATERONE |
| 10003560 | 10002260 | 1.77 | 90.4 | Palliative (P) | 2017-07-22 | 2017-07-23 | Capecitabine + Cisplatin | 02 | N | 10482169 | ABIRATERONE |
| 10003575 | 10002270 | 1.7 | 78.4 | Disease modification (D) | 2016-06-15 | 2016-06-23 | Cisplatin + Etoposide (3 day) | 2 | N | 10482879 | ABIRATERONE |
| 10003624 | 10002297 | null | null | Palliative (P) | 2015-12-30 | 2015-12-30 | BCG Intravesical | 02 | N | 10484477 | ABIRATERONE |
| 10003691 | 10002334 | 1.59 | 66.75 | Curative (C) | 2018-04-30 | 2018-04-30 | Bortezomib (weekly) | 2 | Y | 10486352 | ABIRATERONE |
| 10003694 | 10002336 | null | 77.5 | Curative (C) | 2012-12-30 | 2018-02-17 | EC | 2 | N | 10486401 | ABIRATERONE |
| 10003695 | 10002336 | 1.73 | 83 | Palliative (P) | null | 2017-11-08 | CHOP - 21 days | N | N | 10486401 | ABIRATERONE |
| 10003469 | 10002201 | null | 87.599 | Curative (C) | 2014-04-19 | 2014-04-20 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | null | 10479416 | ABIRATERONE |
| 10003734 | 10002357 | 1.8 | 96.2 | null | 2017-12-05 | 2017-12-05 | Gemcitabine + Capecitabine | 2 | N | 10487591 | ABIRATERONE |
| 10003748 | 10002365 | 1.78 | null | Palliative (P) | 2018-08-15 | 2018-09-10 | CHOP - 14 days | N | Y | 10487962 | ABIRATERONE |
| 10003425 | 10002179 | 1.57 | 68.4 | Palliative (P) | 2017-01-28 | 2017-02-17 | CAPECITABINE + GEMCITABINE | 02 | N | 10476675 | ABIRATERONE |
| 10003444 | 10002190 | 1.76 | 85 | Disease modification (D) | null | 2015-10-15 | EC | N | N | 10478482 | ABIRATERONE |
| 170012937 | 170004694 | null | 57.1 | Palliative (P) | 2017-11-07 | 2017-11-23 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 170001301 | ABIRATERONE |
| 210022712 | 210014022 | 1.78 | 82.7 | null | 2018-02-01 | 2018-02-01 | Bevacizumab + Temozolomide | null | N | 210040382 | ABIRATERONE |
| 190013685 | 190008301 | 1.73 | 65 | null | 2013-10-01 | 2013-10-04 | CETUXIMAB + IRINOTECAN | 02 | N | 190024974 | ABIRATERONE |
| 180000028 | 180000265 | null | null | Disease modification (D) | null | 2016-07-28 | Temozolomide + RT | N | N | 180018359 | ABIRATERONE |
| 10003304 | 10002112 | 1.85 | 71 | Adjuvant (A) | 2015-03-11 | 2015-03-15 | IMATINIB | N | N | 10469047 | ABIRATERONE |
| 200015470 | 200006551 | 1.67 | 68 | Curative (C) | 2017-02-16 | 2017-02-19 | Ixazomib + Lenalidomide | 01 | Y | 200045489 | ABIRATERONE |
| 200015545 | 200031766 | 0 | 0 | Palliative (P) | 2017-05-17 | 2017-05-17 | MUK 8 TRIAL | N | N | 200045955 | ABIRATERONE |
| 170013184 | 170004783 | 1.6 | null | Palliative (P) | null | 2019-03-17 | Carboplatin + Etoposide iv&po | N | null | 170014003 | ABIRATERONE |
| 190011643 | 190008384 | 1.52 | 75.3 | Palliative (P) | 2015-10-27 | 2015-11-21 | ECarboX | 02 | N | 190020615 | ABIRATERONE |
| 200016067 | 200006785 | 1.66 | 0 | Palliative (P) | 2018-05-08 | 2018-05-22 | Bortezomib + prednisolone + MELPHALAN + prednisolone | Y | N | 200040958 | ABIRATERONE |
| 200030358 | 200015808 | null | 66 | null | 2014-01-06 | 2014-01-06 | BCG Intravesical | N | N | 200045854 | ABIRATERONE |
| 210012939 | 210003911 | 1.79 | 62.7 | null | 2015-10-16 | 2015-10-19 | POMALIDOMIDE | 02 | N | 210040807 | ABIRATERONE |
| 210012991 | 210003927 | null | 184 | Disease modification (D) | 2017-03-02 | 2017-03-09 | BEP 5 Day | 2 | N | 210040931 | ABIRATERONE |
| 210013010 | 210003935 | 1.66 | null | null | 2013-03-20 | 2013-04-07 | Azacitidine | N | null | 210041014 | ABIRATERONE |
| 210013064 | 210003955 | 1.65 | 88.1 | null | null | 2016-12-12 | IVE-R | N | null | 210041193 | ABIRATERONE |
| 210013182 | 210003989 | 1.87 | 75 | Curative (C) | 2014-08-29 | 2014-11-22 | Etoposide IV | N | N | 210041598 | ABIRATERONE |
| 210013276 | 210004024 | 1.81 | null | Disease modification (D) | 2018-04-09 | 2018-04-30 | LOMUSTINE + PROCARBAZINE + VINCRISTINE | N | null | 210041909 | ABIRATERONE |
| 210013278 | 210004025 | 1.65 | 103.9 | Adjuvant (A) | 2014-11-24 | 2014-11-24 | UKALL XII Induction Phase 2 | 02 | N | 210041925 | ABIRATERONE |
| 200016055 | 200006780 | 1.73 | 0 | Disease modification (D) | 2018-04-09 | 2018-04-15 | Cisplatin +Fluorouracil (3 wk) | N | N | 200039243 | ABIRATERONE |
| 210013638 | 210038491 | 1.83 | 69.35 | Adjuvant (A) | 2017-04-23 | 2017-04-26 | Carboplatin + Etoposide iv&po | N | N | 210030411 | ABIRATERONE |
| 210013917 | 210004240 | 1.76 | 17.9 | Disease modification (D) | 2017-02-08 | 2017-02-08 | CISPLATIN + LOMUSTINE + VINCRISTINE | 2 | N | 210038800 | ABIRATERONE |
| 210022574 | 210013879 | 1.57 | 82.3 | Curative (C) | 2017-04-18 | 2017-05-01 | PNET 4 HIT-SIOP Maintenance | N | N | 210033199 | ABIRATERONE |
| 220009688 | 220016555 | 1.61 | 78.4 | null | 2018-01-08 | 2018-01-08 | CARBOPLATIN + FLUOROURACIL | N | N | 220028561 | ABIRATERONE |
| 210028215 | 210013976 | 1.57 | 28 | Palliative (P) | 2016-06-12 | 2016-06-27 | Cyclophosphamide High Dose | 02 | N | 210037404 | ABIRATERONE |
| 210031536 | 210022635 | 0 | 98.6 | Curative (C) | 2016-05-18 | 2016-08-11 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | N | 210031032 | ABIRATERONE |
| 210031579 | 210013955 | null | 81 | Curative (C) | null | 2014-10-20 | RUXOLITINIB | Y | N | 210036485 | ABIRATERONE |
| 210031594 | 210022730 | 1.81 | 93 | Adjuvant (A) | 2015-11-23 | 2015-12-21 | ALL UKALL2003 C: Ph VII Maintenance | N | N | 210038996 | ABIRATERONE |
| 210038354 | 210013148 | null | 87.6 | Palliative (P) | 2020-11-03 | 2020-11-10 | CLARITY Trial | 02 | N | 210039036 | ABIRATERONE |
| 10003697 | 10002337 | 1.68 | 90.6 | Palliative (P) | 2017-09-12 | 2017-10-02 | Chlorambucil | N | N | 10486537 | ABIRATERONE |